Year: 2017

joimax® elevates its presence across Europe and Asia

Irvine, CA – June 7, 2017 – Over the last few weeks, joimax® participated in numerous scientific meetings, held across Europe and Asia. During these meetings, the German-based company reiterated its position as market leader for endoscopic minimally invasive spine surgery. Starting in early May, joimax® exhibited at this years’ Global Spine Congress (GSC, http://www.gsc2017.org)
READ MORE

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System. The patented device generates electrical power for
READ MORE

joimax® shows again strong growth trend in 2016 and gets issued next new patents holding now more than 150 patents and trademarks worldwide

Karlsruhe, Germany – January 17th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007
READ MORE